Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05935410 · ClinicalTrials.gov registry record · NA

Diabetes Education/Skills Training and Social Needs Resolution Intervention

A NA study of Type 2 Diabetes, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05935410: Recruiting NA study of Type 2 Diabetes, sponsored by Medical College of Wisconsin.

NCT05935410 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 100 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05935410, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will test the preliminary efficacy of a nurse case-manager, telephone-delivered intervention that provides diabetes self-management education and skills training and resolves the unmet social needs of older African Americans with poorly controlled type 2 diabetes by randomizing 100 African Americans aged 50 years and older with poorly controlled type 2 diabetes to the Combined Diabetes Education/Skills Training and Social Needs Resolution (DM Social Needs) Intervention (n=50) and usual care (n=50) arms. The aims of this study are: Aim 1: Test the preliminary efficacy of the DM Social Needs intervention on clinical outcomes in older AAs with uncontrolled type 2 diabetes. Aim 2: Test the preliminary efficacy of the DM Social Needs intervention on patient reported outcomes in older AAs with uncontrolled type 2 diabetes.

Primary Outcome

About 10cc of blood will be drawn by trained phlebotomists and sent to the lab for testing.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL DM Social Needs

Study Locations (1)

Wisconsin

  • Aprill Dawson - Milwaukee

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-08-01
Est. Completion 2025-11
Phase NA
Medical College of Wisconsin

447 total trials

What NCT05935410 shows while recruiting

NCT05935410 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05935410 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05935410 about?

NCT05935410 is a clinical study titled "Diabetes Education/Skills Training and Social Needs Resolution Intervention". This study will test the preliminary efficacy of a nurse case-manager, telephone-delivered intervention that provides diabetes self-management education and skills training and resolves the unmet social needs of older African Americans with poorly controlled type 2 diabetes by randomizing 100 Africa...

What is the current status of trial NCT05935410?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-08-01. Estimated completion is 2025-11.

What conditions does trial NCT05935410 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05935410?

The interventions under investigation include: Usual Care (BEHAVIORAL), DM Social Needs (BEHAVIORAL).

Who is sponsoring clinical trial NCT05935410?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05935410 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05935410's enrollment target sits among peer trials

100 152nd of 327 higher than 166 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05935410, the US trial registry maintained by the National Library of Medicine. NCT05935410 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.